Navigation Links
Rare disease provides clues about enzyme role in arrhythmias
Date:12/11/2008

A University of Iowa study provides insight into a calcium-sensing enzyme already known to play a role in irregular heartbeats and other critical functions. The researchers showed that the enzyme, calmodulin kinase II (CaM kinase II), contributes to arrhythmia in an extremely rare disease called Timothy syndrome and that inhibiting the enzyme prevents irregular heartbeats.

The findings, which involved a new cellular model, could help with developing treatments for irregular heartbeat in people with this syndrome as well as in the general population. There also could be implications for understanding other conditions such as autism. The study results were published online Nov. 10 by the journal Circulation.

Timothy syndrome has been reported in only about 20 people worldwide. In addition to causing an irregular heartbeat, Timothy syndrome can cause a malformed heart, autism and other nervous system problems. Timothy Syndrome is a type of long QT syndrome, which can cause sudden death in people with normal-appearing hearts.

"We focused on the multisystem disease Timothy syndrome and showed that its hallmark fatal heart disease, which typically is fatal by age 3, involves activation of the enzyme CaM kinase II. We also showed that inhibiting this enzyme prevented irregular heartbeats in adult rat heart cells engineered to express the Timothy syndrome disease gene," said study author Mark Anderson, M.D., Ph.D., professor of internal medicine and molecular physiology and biophysics at the University of Iowa Carver College of Medicine.

CaM kinase II was already known to play a role in arrhythmias but the study helps uncover the enzyme's interplay with calcium channels, which provide the main way for calcium to enter heart cells. Calcium is needed to trigger each heartbeat and to help regulate cell survival, metabolism and gene transcription. In Timothy syndrome, a mutation causes the calcium channel to be malformed. The heart muscle then takes longer to recharge between beats and can lead to irregular heartbeat.

"The findings raise the possibility that CaM kinase II is a 'missing link' that connects this calcium channel mutation to arrhythmia and possibly other problems, such as autism," said Anderson, who also holds the Potter-Lambert Chair in Cardiology and is a member of the University of Iowa Heart and Vascular Center. "Our findings add more evidence that by acting on CaM kinase II, you could directly affect pathways that cause unwanted developmental and neurological changes."

"In contrast to sodium channels or potassium channels, there are very few diseases that cause mutations in calcium channels. Experts believe calcium is too important to 'futz' around with, perhaps accounting for the very severe nature and early death associated with patients with Timothy syndrome," Anderson added.

While previous researchers had observed defects in calcium channels in other cells, those cells did not have the coordinated electrical function of a heart. The University of Iowa team, using the expertise of Bill Thiel, Ph.D., postdoctoral trainee, and Peter Mohler, Ph.D., associate professor of internal medicine and a Pew Scholar, developed and assessed a cellular model to more clearly reveal the function that helps drive heartbeats.

"By studying this mutant channel in an adult rat heart cell that had all the proteins and machinery of a normal heart cell, we obtained a much more complete picture of how the disease works," Anderson said. "When CaM kinase II was turned on in the cellular model, the activation was responsible for the heart rhythm problems. In contrast, when we inhibited the enzyme using a peptide, the disease features healed, the electrical oscillations resolved and the action potential was corrected."

Even though the calcium channel defect in Timothy syndrome is relatively tiny, the defect seriously affects the ability of the heart to keep a regular beat, Anderson said.

"The defect causes the channel to close too slowly, and this in turn amplifies CaM kinase II, which in turn can cause disease," he said. "You can't completely block calcium channels because you need some function to initiate heartbeats. Ideally, we would find a way to allow the defective channel to operate but without allowing the CaM kinase II to be over activated."


'/>"/>

Contact: Becky Soglin
becky-soglin@uiowa.edu
319-335-6660
University of Iowa
Source:Eurekalert

Related biology news :

1. Antioxidant overload may underlie a heritable human disease
2. Gender, coupled with diabetes, affects vascular disease development
3. Study links cat disease to flame retardants in furniture and to pet food
4. Humans fostering forest-destroying disease
5. Emerging (disease) markets
6. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
7. Clemson chemists discover new way antioxidants fight debilitating diseases
8. Finding that 1-in-a-billion that could lead to disease
9. Study shows link between alcohol consumption and hiv disease progression
10. Natural chemical found in broccoli helps combat skin blistering disease
11. 60 second test could help early diagnosis of common brain diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/14/2017)... IBM ) is introducing several innovative partner startups at ... between startups and global businesses, taking place in ... startups will showcase the solutions they have built with IBM ... France is one of the most ... increase in the number of startups created between 2012 and ...
(Date:5/16/2017)... 2017  Veratad Technologies, LLC ( www.veratad.com ), an ... identity verification solutions, announced today they will participate as ... 15 thru May 17, 2017, in Washington ... Center. Identity impacts the lives of ... quickly evolving digital world, defining identity is critical to ...
(Date:5/6/2017)... -- RAM Group , Singaporean based technology ... biometric authentication based on a novel  quantum-state ... perform biometric authentication. These new sensors are based on a ... Group and its partners. This sensor will have widespread ... security. Ram Group is a next generation sensor ...
Breaking Biology News(10 mins):
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... a collaboration with Koch Agronomic Services (Koch) to feature new innovations aimed at ... to broadcast first quarter 2018. American Farmer airs Tuesdays at 8:30aET on RFD-TV. ...
(Date:9/20/2017)... ... September 20, 2017 , ... Proscia Inc. ... , a provider of whole slide imaging solutions, are hosting a pre-conference workshop ... entitled “Successfully Deploying a Best-in-Class Strategy for Digital Pathology,” will feature Proscia CEO, ...
(Date:9/20/2017)... ... 20, 2017 , ... RoviSys, a leading independent provider of ... of an office in Taipei, Taiwan. This new location allows RoviSys to better ... relationships in the region. Located in the Neihu area of Taipei, the office ...
(Date:9/19/2017)... ... ... Biopharma ’s CEO and founder, Dr. Bob Harman DVM, MPVM, is featured in an interview ... Rising Tide". Dr. Harman and Dr. Riordan met in 2003 and have remained in ... of stem cell therapy and a fast friendship was formed. , Dr. Harman has been ...
Breaking Biology Technology: